Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Longitudinal Tracking of MDS Patients Using Next Generation Sequencing Provides a Predictive Measure for Azacitidine Response and AML Progression

Blood (2016) 128 (22): 52.

https://doi.org/10.1182/blood.V128.22.52.52

Published: 2016

Journal Articles

Comparable Outcomes with Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients with or without Aplastic Anemia in a Prospective Korean PNH Registry

Jun Ho Jang, Jin Seok Kim, MD PhD, Deog-Yeon Jo, MD PhD, Je-Hwan Lee, MD PhD, Chul Won Choi, MD PhD, Hyeoung Joon Kim, MD PhD, Jong-Ho Won, MD PhD, Joo Seop Chung, MD PhD, Hawk Kim, MD PhD, Jae-Hoon Lee, MD PhD, Sang Kyun Sohn, MD PhD, Jeong A Kim, MD PhD, Jong Wook Lee, MD PhD

Blood (2015) 126 (23): 4789.

https://doi.org/10.1182/blood.V126.23.4789.4789

Published: 2015

Journal Articles

Ineffective Corticosteroid Treatment for Hemolysis Management of Paroxysmal Nocturnal Hemoglobinuria

Jong Wook Lee, MD PhD, Jun Ho Jang, MD PhD, Je-Hwan Lee, MD PhD, Deog-Yeon Jo, MD PhD, Jin Seok Kim, Yong Park, MD PhD, Sang Kyun Sohn, MD PhD, Jun Sung Park, MD PhD, Chul Won Choi, MD PhD, Joo Seop Chung, MD PhD, Jae Hoon Lee, MD PhD, Jeong A Kim, MD PhD, Jong-Ho Won, MD PhD

Blood (2014) 124 (21): 5151.

https://doi.org/10.1182/blood.V124.21.5151.5151

Published: 2014

Journal Articles

Weekly Four Times Rituximab Consolidation Following Reduced Cycles Of R-CHOP Induction Chemotherapy In Extremely Elderly Patients With Diffuse Large B Cell Lymphoma

Deok-Hwan Yang, MD, PhD, Won Seog Kim, Young-Rok Do, PhD, Sung Yong Oh, Min Kyoung Kim, Yeung-Chul Mun, Ho-Jin Shin, Jae-Yong Kwak, Hye Jin Kang, Jong-Ho Won, MD, PhD, Jung hye Kwon, Hyo Jung Kim, MD, PhD, Cheolwon Suh, Je-Jung Lee, MD, PhD

Blood (2013) 122 (21): 3031.

https://doi.org/10.1182/blood.V122.21.3031.3031

Published: 2013

Journal Articles

Efficacy Of Ruxolitinib In Korean Myelofibrosis Patients and Cases Complicated TB Lymphadenitis During The Treatment

Yeo-Kyeoung Kim, MD, PhD, Se Ryeon Lee, MD, PhD, Yong Park, MD, PhD, Chul Won Choi, MD, PhD, Soo Jeong Kim, MD, PhD, Ho-Young Yhim, MD, PhD, Inho Kim, Doyeun Oh, MD, PhD, Yeung-Chul Mun, Sung-Nam Lim, MD, PhD, Jeong-A Kim, PhD, MD, Myung-Geun Shin, MD, PhD, Jong-Ho Won, MD, PhD

Blood (2013) 122 (21): 1596.

https://doi.org/10.1182/blood.V122.21.1596.1596

Published: 2013

Journal Articles

Whole Exome Sequencing Analysis in AML with Normal Karyotype Not Harboring FLT3/ITD Mutation Reveals Novel Genetic Alterations.

Blood (2012) 120 (21): 2593.

https://doi.org/10.1182/blood.V120.21.2593.2593

Published: 2012

Journal Articles

Prospective Cohort Study with Risk-Adapted Central Nervous System (CNS) Evaluation in Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP: Analysis of Incidence and Risk Factors for Secondary CNS Involvement.

Blood (2012) 120 (21): 2683.

https://doi.org/10.1182/blood.V120.21.2683.2683

Published: 2012

Journal Articles

NPM1, IDH1/2 and DNAH11 Gene Mutations Can Improve a Prognostic Stratification of Acute Myeloid Leukemia Patients with Normal Karyotype but Not Harboring FLT3/ITD Mutation.

Yeo-Kyeoung Kim, MD, PhD, Il-Kwon Lee, PhD, Dennis Dong Hwan Kim, MD, PhD, Chul Won Jung, MD, PhD, Jun-Ho Jang, MD, PhD, Hee Je Kim, MD, PhD, Joon Ho Moon, MD, Sang Kyun Sohn, MD, Jong-Ho Won, MD, PhD, Sung-Hyun Kim, Jungwon Huh, MD, PhD, Namshin Kim, PhD, Yun Gyeong Lee, PhD, Sung-Hoon Jung, MD, Je-Jung Lee, MD, PhD, Hyeoung-Joon Kim, MD, PhD

Blood (2012) 120 (21): 2534.

https://doi.org/10.1182/blood.V120.21.2534.2534

Published: 2012

Journal Articles

Fludarabine, Cytarabine, and Attenuated-Dose Idarubicin (m-FLAI) Induction for Elderly Patients with Acute Myeloid Leukemia: Results of a Multicenter Phase II Study,

Blood (2011) 118 (21): 3626.

https://doi.org/10.1182/blood.V118.21.3626.3626

Published: 2011

Journal Articles

Busulfan, Melphalan and Etoposide Followed by Autologous Stem Cell Transplantation on Patients with Non-Hodgkin's Lymphoma: Multicenter Study From Consortium for Improving Survival of Lymphoma (CISL) in Korea

Kyoung Ha Kim, M.D., Won Seog Kim, Sung-Kyu Park, Mark Hong Lee, MD, PhD, Sang Kyun Sohn, Cheolwon Suh, MD, Hye Jin Kang, Chul Won Choi, MD, PhD, Ho Sup Lee, Sung Hwa Bae, Jinny Park, Eunkyung Park, MD, PhD, Jae-Yong Kwak, MD, PhD, Han Jo Kim, Se-Hyung Kim, MD, Jong-Ho Won, MD, PhD

Blood (2011) 118 (21): 2021.

https://doi.org/10.1182/blood.V118.21.2021.2021

Published: 2011

Journal Articles

Bone Marrow Cellularity Is a Single Most Important Independent Prognostic Factor In AML Patients with t(8;21)

Blood (2010) 116 (21): 1707.

https://doi.org/10.1182/blood.V116.21.1707.1707

Published: 2010

Journal Articles

Prognostic Factors on Survival After Hematopoietic Stem Cell Transplantation for Adult Over 40 Years In Aplastic Anemia.

Hawk Kim, Jae-Yong Kwak, Byung Soo Kim, Sung Hyun Kim, Sung-Hwa Bae, MD, Sang Kyun Sohn, Ho-Jin Shin, Jong-Ho Won, MD, PhD, Sung-Soo Yoon, Deog-Yeon Jo, MD, PhD, Young-Don Joo, Jung Hye Choi, Myung Soo Hyun, Kyoo Hyung Lee

Blood (2010) 116 (21): 1315.

https://doi.org/10.1182/blood.V116.21.1315.1315

Published: 2010

Journal Articles

The Comparison Between Matched Related Donor and Alternative Donor for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acquired Aplastic Anemia: KSBMT2007-02 Study

Blood (2008) 112 (11): 2997.

https://doi.org/10.1182/blood.V112.11.2997.2997

Published: 2008

Journal Articles

Low Incidence of Thromboembolism in Asian Multiple Myeloma Patients Treated with Thalidomide: Do We Really Need Prophylaxis for Thromboembolism in Asian Population?

Youngil Koh, Soo-Mee Bang, MD, PhD, Jae Hoon Lee, Hwi-Joong Yoon, Young-Rok Do, PhD, Hun-Mo Ryoo, Nari Lee, Seok Jin Kim, MD, PhD, Sung-Soo Yoon, MD, PhD, Jong-Ho Won, MD, PhD, Yeung-Chul Mun, MD, PhD, Moon-Hee Lee, Jong-Youl Jin, MD, PhD, Hyo-Jung Kim, HyeonSeok Eom, MD, PhD, Min Kyoung Kim, MD, Hyun Chun Shin, Korean Multiple Myeloma Working Party

Blood (2008) 112 (11): 5146.

https://doi.org/10.1182/blood.V112.11.5146.5146

Published: 2008

Journal Articles

Serum B-Cell Activating Factor (BAFF) in Diffuse Large B-Cell Lymphoma: Its Prognostic Significance in the Rituximab Era.

Seok Jin Kim, MD, PhD, Hwa Jung Sung, MD, PhD, Chul Won Choi, MD, PhD, In Sun Kim, MD, PhD, Byung Soo Kim, MD, PhD, Soo-Young Yoon, MD, PhD, Jong-Ho Won, MD, PhD, Jun Suk Kim, MD, PhD

Blood (2007) 110 (11): 1575.

https://doi.org/10.1182/blood.V110.11.1575.1575

Published: 2007

Journal Articles

Mesenchymal Stem Cells Improve Wound Healing Via Early Activation of the Matrix Metalloproteinase-9 and Vascular Endothelial Growth Factor: Using a 3-Dimensional Collagen Gel Model.

Jong-Ho Won, MD, PhD, Cheol-Hann Kim, M.D., Moon-Kyun Cho, M.D., Ph.D., Sang-Cheol Lee, M.D., Chan-Kyu Kim, M.D., Nam-Su Lee, M.D., Ph.D., Dae-Sik Hong, M.D., Ph.D., Hee-Sook Park, M.D., Ph.D.

Blood (2007) 110 (11): 3696.

https://doi.org/10.1182/blood.V110.11.3696.3696

Published: 2007

Journal Articles

Two Single Nucleotide Polymorphisms of the ETS2 Transcriptional Factor Gene Predispose Individuals to High-Risk Acute Myelogenous Leukemia (AML).

Il-Kwon Lee, PhD, Jeong-Hwa Choi, MSc, Yeo-Kyeoung Kim, MD, PhD, Hee Nam Kim, MSc, Kyeong-Soo Park, MD, PhD, Je-Jung Lee, MD, PhD, Myung Geun Shin, MD, PhD, Chan Choi, MD, PhD, Hoon Kook, MD, PhD, Tae Ju Hwang, MD, PhD, Moo Rim Park, MD, PhD, Deog Yeon Jo, MD, PhD, Jong Ho Won, MD, PhD, Hyeoung-Joon Kim, MD, PhD

Blood (2005) 106 (11): 2729.

https://doi.org/10.1182/blood.V106.11.2729.2729

Published: 2005

Journal Articles

Overcoming TNF- α Induced Suppression of Erythroid Differentiation of Human Cord Blood CD34+ Cells with Arsenic Trioxide.

Jong-Ho Won, MD, PhD, Hee-Jeong Cheong, Sook-Ja Kim, Sang-Byung Bae, MD, Chan-Kyu Kim, MD, Nam-Su Lee, MD, Ph.D, Kyu-Taeg Lee, MD, Sung-Kyu Park, MD, Ph.D, Dae-Sik Hong, MD, Ph.D, Hee-Sook Park, MD, Ph.D

Blood (2005) 106 (11): 3451.

https://doi.org/10.1182/blood.V106.11.3451-a.3451-a

Published: 2005

Journal Articles

Human Mesenchymal Stem Cells Injected Via Portal Vein Are Differentiated into Human Hepatocytes in Regenerating Rat Liver.

Jong-Ho Won, MD, PhD, Dong-Ho Choi, MD, PhD, Jung-Hoon Kim, MD, Sook-Ja Kim, Hee-Jeong Cheung, Nam-Su Lee, MD, PhD, Hee-Sook Park, MD, PhD

Blood (2005) 106 (11): 1694.

https://doi.org/10.1182/blood.V106.11.1694.1694

Published: 2005

NARROW

Longitudinal Tracking of MDS Patients Using Next Generation Sequencing Provides a Predictive Measure for Azacitidine Response and AML Progression

Comparable Outcomes with Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients with or without Aplastic Anemia in a Prospective Korean PNH Registry

Ineffective Corticosteroid Treatment for Hemolysis Management of Paroxysmal Nocturnal Hemoglobinuria

Weekly Four Times Rituximab Consolidation Following Reduced Cycles Of R-CHOP Induction Chemotherapy In Extremely Elderly Patients With Diffuse Large B Cell Lymphoma

Efficacy Of Ruxolitinib In Korean Myelofibrosis Patients and Cases Complicated TB Lymphadenitis During The Treatment

Whole Exome Sequencing Analysis in AML with Normal Karyotype Not Harboring FLT3/ITD Mutation Reveals Novel Genetic Alterations.

Prospective Cohort Study with Risk-Adapted Central Nervous System (CNS) Evaluation in Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP: Analysis of Incidence and Risk Factors for Secondary CNS Involvement.

NPM1, IDH1/2 and DNAH11 Gene Mutations Can Improve a Prognostic Stratification of Acute Myeloid Leukemia Patients with Normal Karyotype but Not Harboring FLT3/ITD Mutation.

Fludarabine, Cytarabine, and Attenuated-Dose Idarubicin (m-FLAI) Induction for Elderly Patients with Acute Myeloid Leukemia: Results of a Multicenter Phase II Study,

Busulfan, Melphalan and Etoposide Followed by Autologous Stem Cell Transplantation on Patients with Non-Hodgkin's Lymphoma: Multicenter Study From Consortium for Improving Survival of Lymphoma (CISL) in Korea

Bone Marrow Cellularity Is a Single Most Important Independent Prognostic Factor In AML Patients with t(8;21)

Prognostic Factors on Survival After Hematopoietic Stem Cell Transplantation for Adult Over 40 Years In Aplastic Anemia.

The Comparison Between Matched Related Donor and Alternative Donor for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acquired Aplastic Anemia: KSBMT2007-02 Study

Low Incidence of Thromboembolism in Asian Multiple Myeloma Patients Treated with Thalidomide: Do We Really Need Prophylaxis for Thromboembolism in Asian Population?

Serum B-Cell Activating Factor (BAFF) in Diffuse Large B-Cell Lymphoma: Its Prognostic Significance in the Rituximab Era.

Mesenchymal Stem Cells Improve Wound Healing Via Early Activation of the Matrix Metalloproteinase-9 and Vascular Endothelial Growth Factor: Using a 3-Dimensional Collagen Gel Model.

Two Single Nucleotide Polymorphisms of the ETS2 Transcriptional Factor Gene Predispose Individuals to High-Risk Acute Myelogenous Leukemia (AML).

Overcoming TNF- α Induced Suppression of Erythroid Differentiation of Human Cord Blood CD34+ Cells with Arsenic Trioxide.

Human Mesenchymal Stem Cells Injected Via Portal Vein Are Differentiated into Human Hepatocytes in Regenerating Rat Liver.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only